Michael Dyer, MD is an Assistant Professor of Radiation Oncology at the Boston University School of Medicine. Previously, he worked as the Resident Coordinator for Medical Student Rotations at Massachusetts General Hospital. Dr. Dyer is also an Ad Hoc Reviewer for the International Journal of Radiation Oncology and a member of the Massachusetts Medical Society, and the American Medical Association. He is a member-in-training of the American Society for Radiation Oncology and the American Society of Clinical Oncology.
- Harvard Medical School, MD
- Brown University, AB
- Published on 9/1/2018
Burger EA, Dyer MA, Sy S, Palefsky JM, de Pokomandy A, Coutlee F, Silverberg MJ, Kim JJ. Development and Calibration of a Mathematical Model of Anal Carcinogenesis for High-Risk HIV-Infected Men. J Acquir Immune Defic Syndr. 2018 Sep 01; 79(1):10-19. PMID: 29757775.
- Published on 7/24/2018
Yan SX, Qureshi MM, Suzuki K, Dyer M, Truong MT, Litle V, Mak KS. Definitive treatment patterns and survival in stage II non-small cell lung cancer. Lung Cancer. 2018 Oct; 124:135-142. PMID: 30268452.
- Published on 1/1/2016
Dyer, M. A., Chen, M., Braccioforte, M. H., Moran, B. J., D’Amico, A. V. Journal of Radiation Oncology. Comorbidity and androgen deprivation therapy use in men undergoing high-dose radiation for unfavorable-risk prostate cancer. Springer Publishing. New York. 2016.
- Published on 12/15/2015
Schoenfeld JD, Mahadevan A, Floyd SR, Dyer MA, Catalano PJ, Alexander BM, McDermott DF, Kaplan ID. Ipilmumab and cranial radiation in metastatic melanoma patients: a case series and review. J Immunother Cancer. 2015; 3:50. PMID: 26672895.
- Published on 6/22/2014
Dyer MA, Arvold ND, Chen YH, Pinnell NE, Mitin T, Lee EQ, Hodi FS, Ibrahim N, Weiss SE, Kelly PJ, Floyd SR, Mahadevan A, Alexander BM. The role of whole brain radiation therapy in the management of melanoma brain metastases. Radiat Oncol. 2014 Jun 22; 9:143. PMID: 24954062.
- Published on 1/1/2013
Cather C, Dyer MA, Burrell HA, Hoeppner B, Goff DC, Evins AE. An Open Trial of Relapse Prevention Therapy for Smokers With Schizophrenia. J Dual Diagn. 2013; 9(1):87-93. PMID: 23750123.
- Published on 7/15/2012
Dyer MA, Kelly PJ, Chen YH, Pinnell NE, Claus EB, Lee EQ, Weiss SE, Arvold ND, Lin NU, Alexander BM. Importance of extracranial disease status and tumor subtype for patients undergoing radiosurgery for breast cancer brain metastases. Int J Radiat Oncol Biol Phys. 2012 Jul 15; 83(4):e479-86. PMID: 22704705.
- Published on 1/25/2010
Qureshi A, Nan H, Dyer M, Han J. Polymorphisms of FAS and FAS ligand genes and risk of skin cancer. J Dermatol Sci. 2010 Apr; 58(1):78-80. PMID: 20219325.
- Published on 1/1/2009
Dyer, M. A., Lieberman, G. Etiology and diagnosis of intracranial hypertension: Using MRI to narrow an index patient’s differential. Harvard University. Cambridge. 2009.
- Published on 3/5/2008
Dyer MA, Freudenreich O, Culhane MA, Pachas GN, Deckersbach T, Murphy E, Goff DC, Evins AE. High-dose galantamine augmentation inferior to placebo on attention, inhibitory control and working memory performance in nonsmokers with schizophrenia. Schizophr Res. 2008 Jul; 102(1-3):88-95. PMID: 18325740.
View 2 more publications: View full profile at BUMC